Literature DB >> 365218

Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.

D A Lane, F E Preston, M E VanRoss, V V Kakkar.   

Abstract

The fibrinogen and fibrin degradation products (FDP) in serum samples taken from nine patients with suspected disseminated intravascular coagulation have been characterized using a method of immunoprecipitation followed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. Aall of the serum samples contained a fragment with the same electrophoretic mobility as fibrinogen fragment X, while the majority also had evidence of fragments with similar mobility to fibrinogen fragments Y and D. In eight of the nine serum samples there was strong evidence of the D-dimer fragment that is released by plasmin lysis of crosslinked fibrin. Also present in all but one of the samples were fragments of higher molecular weight than fibrinogen which were probably soluble, non-clottable, factor XIIIa induced crosslinked derivatives of fibrinogen. These results suggest that during disseminated intravascular coagulation thrombin and activated factor XIII act upon fibrin(ogen) to form complexes that are subsequently lysed by plasmin to produce soluble crosslinked derivatives of fibrin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365218     DOI: 10.1111/j.1365-2141.1978.tb05837.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Role of fibrin D-dimer testing in emergency medicine.

Authors:  A Wakai; A Gleeson; D Winter
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

2.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Increased concentrations of D-dimers in newborn infants.

Authors:  I R Hudson; B E Gibson; J Brownlie; B M Holland; T L Turner; R G Webber
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

4.  Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.

Authors:  K Yoshioka; S Mizuno; H Miyata; S Maki
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

5.  Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions.

Authors:  Leena Gharat; Govind P Rathod; Shilpa Kandalgaonkar
Journal:  J Int Oral Health       Date:  2013-10-26

6.  Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

Authors:  A L Jones; T J Powles; J G Treleaven; J F Burman; M C Nicolson; H I Chung; S E Ashley
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.